Free Trial

Intuitive Surgical, Inc. $ISRG Shares Bought by United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund

Intuitive Surgical logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • United Super Pty Ltd increased its Intuitive Surgical stake by 8.4% in the fourth quarter, buying 7,886 more shares and bringing its total to 102,154 shares worth about $57.9 million.
  • Intuitive Surgical reported strong quarterly results, with EPS of $2.50 beating estimates by $0.42 and revenue of $2.77 billion topping forecasts; revenue also rose 23% year over year.
  • Analyst sentiment remains mostly constructive, with the stock carrying a Moderate Buy consensus and an average price target of $576.71, though several firms recently trimmed targets and one downgraded the stock to hold.
  • MarketBeat previews the top five stocks to own by June 1st.

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 102,154 shares of the medical equipment provider's stock after acquiring an additional 7,886 shares during the quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's holdings in Intuitive Surgical were worth $57,856,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Riversedge Advisors LLC lifted its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider's stock valued at $510,000 after acquiring an additional 17 shares during the last quarter. Fiduciary Financial Group LLC lifted its holdings in Intuitive Surgical by 2.1% in the 4th quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider's stock valued at $521,000 after acquiring an additional 19 shares during the last quarter. Prosperity Consulting Group LLC lifted its holdings in Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider's stock valued at $1,804,000 after acquiring an additional 19 shares during the last quarter. Activest Wealth Management lifted its holdings in Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider's stock valued at $50,000 after acquiring an additional 20 shares during the last quarter. Finally, Sunburst Financial Group LLC lifted its holdings in Intuitive Surgical by 4.3% in the 4th quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider's stock valued at $275,000 after acquiring an additional 20 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ISRG. Robert W. Baird upped their price target on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an "outperform" rating in a report on Wednesday, April 22nd. Raymond James Financial cut their price target on shares of Intuitive Surgical from $615.00 to $577.00 and set an "outperform" rating for the company in a report on Wednesday, April 22nd. TD Cowen reduced their price objective on shares of Intuitive Surgical from $660.00 to $585.00 and set a "buy" rating for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group reduced their price objective on shares of Intuitive Surgical from $560.00 to $515.00 and set a "hold" rating for the company in a research note on Wednesday, April 22nd. Finally, Zacks Research lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 30th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $576.71.

Read Our Latest Stock Analysis on Intuitive Surgical

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 105 shares of the company's stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 2,362 shares of the company's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the transaction, the senior vice president owned 3,554 shares in the company, valued at $1,772,308.72. This represents a 39.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 5,481 shares of company stock worth $2,673,871 over the last quarter. Company insiders own 0.60% of the company's stock.

Intuitive Surgical Trading Up 1.2%

ISRG stock opened at $423.63 on Friday. Intuitive Surgical, Inc. has a one year low of $414.30 and a one year high of $603.88. The firm has a market capitalization of $150.03 billion, a PE ratio of 51.35, a P/E/G ratio of 3.34 and a beta of 1.51. The firm has a 50-day moving average of $454.60 and a two-hundred day moving average of $507.01.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts' consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm's quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.81 EPS. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

  • Positive Sentiment: Intuitive Surgical announced Taylor Patton will become Chief Commercial and Marketing Officer effective July 1, while current commercial chief Henry Charlton moves to SVP of Global Business Operations. The change appears to be an internal promotion, suggesting leadership continuity rather than disruption. Article Title
  • Positive Sentiment: The company has also highlighted major updates to its da Vinci 5 robotic surgical system, with more than 100 improvements set to roll out to U.S. customers starting in June. Investors may view that as a sign of continued innovation and potential to support procedure growth. Article Title
  • Positive Sentiment: Recent commentary from market and research outlets has remained favorable, with articles arguing that Intuitive Surgical’s above-average financial growth and optimistic analyst outlook could make the stock attractive to growth investors. Article Title
  • Neutral Sentiment: A market note said Intuitive Surgical underperformed competitors on Wednesday, but the item did not point to a company-specific setback or new fundamental issue. Article Title

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Read More

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines